Mobile-health Network Solutions (NASDAQ:MNDR) and Enovis (NYSE:ENOV) Head-To-Head Review

Mobile-health Network Solutions (NASDAQ:MNDR) and Enovis (NYSE:ENOV) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, dividends, institutional ownership, risk, valuation, earnings and analyst recommendations.

Insider and Institutional Ownership

98.5% of Enovis shares are owned by institutional investors. 2.9% of Enovis shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Analyst Recommendations

This is a summary of recent ratings and target prices for Mobile-health Network Solutions and Enovis, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Mobile-health Network Solutions	1	0	0	0	1.00
Enovis	1	0	7	1	2.89

Enovis has a consensus target price of $44.50, suggesting a potential upside of 96.60%. Given Enovis’ stronger consensus rating and higher possible upside, analysts plainly believe Enovis is more favorable than Mobile-health Network Solutions.

Earnings & Valuation

This table compares Mobile-health Network Solutions and Enovis”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Mobile-health Network Solutions	$7.65 million	0.52	-$3.38 million	N/A	N/A
Enovis	$2.25 billion	0.58	-$1.18 billion	($19.88)	-1.14

Mobile-health Network Solutions has higher earnings, but lower revenue than Enovis.

Profitability

This table compares Mobile-health Network Solutions and Enovis’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Mobile-health Network Solutions	N/A	N/A	N/A
Enovis	-49.92%	10.32%	4.57%

Volatility & Risk

Mobile-health Network Solutions has a beta of -1.14, indicating that its share price is 214% less volatile than the S&P 500. Comparatively, Enovis has a beta of 1.38, indicating that its share price is 38% more volatile than the S&P 500.

Summary

Enovis beats Mobile-health Network Solutions on 11 of the 13 factors compared between the two stocks.

About Mobile-health Network Solutions

Mobile-health Network Solutions, an investment holding company, provides telehealth solutions in Singapore. The company operates in two segments, Telemedicine and Other Services, and Sale of Medicine and Medical Devices. It offers MaNaDr platform, a 360-degree healthcare ecosystem, which connects users and service providers through the range of healthcare services and product offerings that can be accessed through the mobile application and website. The company also provides a range of primary healthcare services, including general medical consultations, treatment and management of acute and chronic conditions in adults and children, vaccinations, and health screenings for work permit applications, as well as pre-employment health screening, children's health services, geriatric care services, and minor surgical procedures. In addition, it offers healthcare and wellness-related products through its online e-commerce platform; wholesale distribution of pharmaceutical products to clinics; and MaNaCare, a platform that provides a range of corporate healthcare and wellness services, including GP, specialist and allied healthcare panel services, tele-consultation services, in-person clinics, on-site health screening, and online marketplace and forum, as well as wellness programs to corporate customers. Further, the company develops IT systems on mobile phone and web portals; operates pharmacies, clinics, and drug stores; and offers beauty and other personal care services, as well as other general medical and health services. The company was founded in 2009 and is headquartered in Singapore.

About Enovis

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments. Its Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. The company's Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. The company distributes its products through independent distributors and directly under the ESAB and DJO brands. Enovis Corporation was formerly known as Colfax Corporation. The company was founded in 1995 and is headquartered in Wilmington, Delaware.